MINI FUTURE LONG - BECTON DICKINSON AND CO. Share Price

Certificat

DE000MB96Q91

Real-time Bid/Ask 14:56:01 20/06/2024 BST
3.26 EUR / 3.33 EUR +14.01% Intraday chart for MINI FUTURE LONG - BECTON DICKINSON AND CO.
Current month+4.33%
1 month-11.62%
Date Price Change
20/06/24 3.24 +12.11%
19/06/24 2.89 -4.62%
18/06/24 3.03 +3.06%
17/06/24 2.94 -2.33%
14/06/24 3.01 +6.74%

Delayed Quote Börse Stuttgart

Last update June 20, 2024 at 02:53 pm

More quotes

Static data

Product typeKnock-Out with Stop Loss
Buy / SellCALL
Underlying BECTON, DICKINSON AND COMPANY
Issuer Morgan Stanley
WKN MB96Q9
ISINDE000MB96Q91
Date issued 26/07/2023
Strike 201.8 $
Maturity Unlimited
Parity 10 : 1
Emission price 8.42
Emission volume N/A
Settlement cash
Currency EUR

Technical Indicators

Highest since issue 9.05
Lowest since issue 1.94
Spread 0.05
Spread %1.54%

Company Profile

Becton, Dickinson and Company specializes in the development, manufacturing and marketing of medical and diagnostic equipment and materials. Net sales break down by family of products as follows: - medical equipment (73.5%): surgical instruments, urological care products, pharmaceutical systems, etc.; - diagnostic materials (18.7%): automated systems for blood testing, mycobacteria detection, and molecular biology, medical biology devices, etc.; - clinical research and development tools (7.8%): tools for discovering drugs and vaccines, studying genes, culturing cells, and manipulating liquids, instruments for sorting and analyzing cells, monoclonal antibodies, etc. Net sales are distributed geographically as follows: the United States (57.4%), Europe/Middle East/Africa (21.9%), Asia (15%) and other (5.7%).
Sector
-
More about the company

Ratings for Becton, Dickinson and Company

Trading Rating
Investor Rating
ESG Refinitiv
A
More Ratings

Consensus: Becton, Dickinson and Company

Sell
Consensus
Buy
Mean consensus
OUTPERFORM
Number of Analysts
18
Last Close Price
233.7 USD
Average target price
279.2 USD
Spread / Average Target
+19.45%
Consensus